Deferoxamine Disease Interactions
There are 5 disease interactions with deferoxamine.
Deferoxamine (applies to deferoxamine) renal dysfunction
Major Potential Hazard, High plausibility.
The use of deferoxamine is contraindicated in patients with severe renal impairment or anuria. Deferoxamine chelates iron and the complexes are primarily eliminated by the kidney.
Deferoxamine (applies to deferoxamine) auditory dysfunction
Moderate Potential Hazard, High plausibility. Applicable conditions: Hearing Loss
Neurotoxicity-related auditory abnormalities such as tinnitus and hearing loss including deafness have occurred after prolonged therapy or large doses of deferoxamine, or in patients with low ferritin levels. Therapy with deferoxamine should be administered cautiously in patients with hearing impairment. Hearing toxicity is usually reversible if detected early and deferoxamine discontinued.
Deferoxamine (applies to deferoxamine) hepatic impairment
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease
No studies of deferoxamine have been performed in patients with hepatic impairment. Caution is advised.
Deferoxamine (applies to deferoxamine) ocular dysfunction
Moderate Potential Hazard, High plausibility. Applicable conditions: Visual Defect/Disturbance
Deferoxamine may cause blurred vision, cataracts, decreased visual acuity, and impaired color, peripheral, and night vision. Ocular toxicities have occurred after prolonged therapy, large doses, and in patients with decreased ferritin levels. Therapy with deferoxamine should be administered cautiously in patients with or predisposed to visual defects. Periodic examination of visual acuity is recommended in patients receiving long term deferoxamine therapy. Ocular dysfunction is usually reversible if detected early and deferoxamine is withdrawn promptly.
Deferoxamine (applies to deferoxamine) respiratory distress syndrome
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Thalassemia
Acute respiratory distress syndrome has been described in patients with acute iron intoxication or thalassemia following treatment with excessively high intravenous doses of deferoxamine. Caution is recommended when using deferoxamine in these patients.
Switch to professional interaction data
Deferoxamine drug interactions
There are 35 drug interactions with deferoxamine.
More about deferoxamine
- deferoxamine consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- Drug class: antidotes
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.